| abstract |
The present invention provides redox drug derivatives. In particular, the present invention provides 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1, 2,3-de]-1,4-benzoxazine-6-carboxylic acid, 1-ethyl-6-fluoro-1,4-dihydro-7-(4-methyl-1-piperazinyl )-4-oxo-3-quinolinecarboxylic acid, (3R,4R,5S)-4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene -Ethyl 1-carboxylate, (3S)-3-(aminomethyl)-5-methylhexanoic acid, (3S)-1-[2-(2,3-dihydro-5-benzofuryl )ethyl]-α-α-diphenyl-3-pyrrolidineacetamide, (1S, 2S, 3S, 4R)-3-[(1S)-1-acetylamino-2-ethyl-butyl] -4-(Diaminomethyleneamino)-2-hydroxy-cyclopentane-1-carboxylic acid and (2R,3R,4S)-4-[(diaminomethylene)amino]-3-acetamido - 2-[(1R,2R)-1,2,3-Trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid redox derivative. |